Purina

Anemia is defined as a decrease in the number of red blood cells (erythrocytes) in circulation in the blood stream. Red blood cells are comprised of hemoglobin an iron-rich protein that delivers oxygen to tissues and organs. Symptoms of anemia may be mild to life threatening depending on the degree of red blood cell depletion. Acute blood loss from trauma, immune-mediated destruction of cells, kidney failure, blood parasites, and bone marrow disease are a few of the numerous causes. Treatment options depend entirely upon the severity and the mechanism responsible for the anemia.

Red blood cells make up the majority of the cells found in circulation. Red cell function is measured in several ways. First, packed-cell volume is the percentage of whole blood that is made up of cells, with a normal value of 35 – 55%. Less than 30% is considered anemia, and less than 20% is life threatening. Absolute red cell count is an estimated number of cells per volume of whole blood. Normal canine and feline blood contains more than five million cells in every microliter (1/1,000,000th of 1 liter). Other tests that determine red blood cell health, but not quantity, include MCV – mean corpuscular volume (size of the cell) and MCHC – mean corpuscular hemoglobin concentration (amount of hemoglobin bound to the cell).

When anemia is discovered, it is categorized as either regenerative or non-regenerative. The bone marrow should respond to anemia by producing more red blood cells; therefore, an increase in the number of immature cells called reticulocytes should be seen on lab results. If there are more than sixty thousand reticulocytes per microliter, the anemia would be considered regenerative. Otherwise, the anemia is called non-regenerative, and a reason for bone marrow suppression should be pursued. Non-regenerative anemia is usually more difficult to treat and is progressive if it is not reversed.

Treatment for acute blood loss may include a blood transfusion. Whole blood or packed red cells are given intravenously to correct the anemia, giving the body time to regenerate its own cells. Corticosteroid is given before a transfusion to avoid rejection of the foreign cells and prevent anaphylaxis (allergic reaction). Blood typing is usually not performed unless multiple transfusions are expected to be necessary, as antibodies to the cells may destroy subsequent transfusions.

A synthetic hormone called Epogen (erythropoietin) can be used to stimulate the bone marrow to produce red blood cells. Erythropoietin is produced by the kidneys; therefore in chronic renal failure, Epogen is supplemented to correct anemia. Antibodies form in response to the Epogen injections however, making repeated injections less and less effective as the renal failure progresses.

In IMHA (immune-mediated hemolytic anemia), the body destroys its own red blood cells for some reason. The treatment for IMHA is immunosuppressive drugs like prednisone and azathioprine (Imuran). These medications stop the immune system from attacking the red blood cells.
Maintenance dosing of steroid is almost always necessary to prevent recurrence of the anemia.

The prognosis for a pet diagnosed as anemic depends on the degree of anemia, whether or not the bone marrow is capable and actively producing new cells, and the underlying disease process that caused the blood loss to begin with. In general, regenerative anemias are more easily treated than non-regenerative forms. The prognosis of the causative disease process will directly determine the outcome.